Autopsy report · NCT01050491
Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma
Cause of deathFunding or business
“sitaxentan is not commercialized anymore”
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 1 year 1 month before it stopped.
- 17 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Sponsor type
- Government (non-US federal)
- Conditions
- Effect of Sitaxsentan on Airway Remodeling in Severe Asthma
- Interventions
- sitaxentan; placebo
- Participants
- 17
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.